Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia
Lane, Andrew A., Garcia, Jacqueline S., Raulston, Evangeline G., Garzon, Jada L., Galinsky, Ilene, Baxter, Emilie W., Leonard, Rebecca, DeAngelo, Daniel J., Luskin, Marlise R., Reilly, Christopher R., Stahl, Maximilian, Stone, Richard M., Vedula, Rahul S., Wadleigh, Martha M., Winer, Eric S., Mughal, Tariq, Brooks, Christopher, Gupta, Ira V., Stevenson, Kristen E., Neuberg, Donna S., Ren, Siyang, Keating, Julia, Konopleva, Marina, Stein, Anthony, Pemmaraju, Naveen
Published in Blood advances (13.02.2024)
Published in Blood advances (13.02.2024)
Get full text
Journal Article
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis
El-Jawahri, Areej, Keenan, Tanya, Abel, Gregory A, Steensma, David P, LeBlanc, Thomas W, Chen, Yi-Bin, Hobbs, Gabriela, Traeger, Lara, Fathi, Amir T, DeAngelo, Daniel J, Wadleigh, Martha, Ballen, Karen K, Amrein, Philip C, Stone, Richard M, Temel, Jennifer S
Published in The Lancet. Haematology (01.06.2016)
Published in The Lancet. Haematology (01.06.2016)
Get more information
Journal Article
Phase 1/2, dose-escalation study of oral NS-018 in patients with primary myelofibrosis (PMF), post-polycythemia vera MF (post-PV MF), or post-essential thrombocythemia MF(post-ET MF)
Verstovsek, Srdan, MD, PhD, Talpaz, Moshe, MD, Ritchie, Ellen, MD, Wadleigh, Martha, MD, Odenike, Olatoyosi M., MD, Jamieson, Catriona, MD, PhD, Stein, Brady, MD, Uno, Tomonori, PhD, Mesa, Ruben A., MD
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article